|
|
 |
The purpose of the Veterinary Public Health group (formerly known as "Grandes Prophylaxies") is to give global support to governmental Veterinary Services, non-governmental organizations, veterinarians and farmer organizations in their effort to control infectious animal diseases of major social and economic importance.
The fast growth and intensification of trade in the global livestock sector, climatic, environmental and animal husbandry changes and a steadily increasing level of recreational outdoor activities will inevitably lead to the emergence and re-emergence of infectious animal diseases of unpredictable risk for human and animal health.
The control of infectious animal disease is ensured by:
- Developing, manufacturing and distributing vaccines against serious infectious animal diseases such as Foot & Mouth Disease, Rabies, Bluetongue, Rinderpest, Contagious Bovine Pleuropneumonia, Peste des Petits Ruminants, Blackleg and Anthrax.
- Building strategic reserves (antigen banks) for contingency plans
- Transferring technology to develop regional capacities
- Actively contributing to the development of effective innovative tools, strategies, policies and regulations vital to controlling infectious diseases of public and veterinary public health importance in developed and developing countries.
To find out what products and services are offered by the location nearest to you, either select a location to the left, or Contact Us.
|
|
|
|
Merial received a breakthrough conditional license for our new Bluetongue vaccine (BTVPUR AlSap™), developed in only 18 months of development.
In response to outbreaks of rabies in several Eastern US states, sales of Merial’s oral rabies vaccine for wildlife rose to an all-time high in the US in 2004.
Merial Brazil has the largest biosafety laboratory in the world for the production of foot-and-mouth-disease vaccine.
|
 |
|
